Craneware PLC
LSE:CRW

Watchlist Manager
Craneware PLC Logo
Craneware PLC
LSE:CRW
Watchlist
Price: 2 320 GBX 4.5% Market Closed
Market Cap: 811.5m GBX
Have any thoughts about
Craneware PLC?
Write Note

Craneware PLC
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Craneware PLC
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Craneware PLC
LSE:CRW
Cash & Cash Equivalents
$34.6m
CAGR 3-Years
-47%
CAGR 5-Years
-6%
CAGR 10-Years
1%
Renalytix PLC
LSE:RENX
Cash & Cash Equivalents
$24.7m
CAGR 3-Years
23%
CAGR 5-Years
259%
CAGR 10-Years
N/A
Cambridge Cognition Holdings PLC
LSE:COG
Cash & Cash Equivalents
ÂŁ3.4m
CAGR 3-Years
-6%
CAGR 5-Years
11%
CAGR 10-Years
8%
Intelligent Ultrasound Group PLC
LSE:IUG
Cash & Cash Equivalents
ÂŁ3m
CAGR 3-Years
-30%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
EMIS Group PLC
LSE:EMIS
Cash & Cash Equivalents
ÂŁ48.5m
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
11%
Doctor Care Anywhere Group PLC
ASX:DOC
Cash & Cash Equivalents
ÂŁ6.1m
CAGR 3-Years
-46%
CAGR 5-Years
29%
CAGR 10-Years
N/A
No Stocks Found

Craneware PLC
Glance View

Market Cap
819.6m GBX
Industry
Health Care

Craneware Plc engages in the provision of software and support services for the healthcare industry. The firm's Value Cycle Solutions has five product families, which include Patient Engagement, Charge Capture & Pricing, Claims Analytics, Cost and Margin Analytics, and Revenue Recovery & Retention. Its Patient Engagement solutions include InSight Medical Necessity, which provides access to medical necessity and prior authorization policies for Medicare, Medicare supplements and commercial payors impacting customers facility. Its Charge Capture & Pricing solution include Chargemaster Toolkit, Trisus Pricing Transparency, Trisus Pharmacy Financial Management, Trisus Pricing Analyzer, Online Reference Toolkit, and others. Its Claims Analytics solution include Trisus Claims Informatics. Its Revenue Recovery & Retention solution include InSight Denials, InSight Audit and Appeals Services.

CRW Intrinsic Value
2 004.47 GBX
Overvaluation 14%
Intrinsic Value
Price

See Also

What is Craneware PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
34.6m USD

Based on the financial report for Jun 30, 2024, Craneware PLC's Cash & Cash Equivalents amounts to 34.6m USD.

What is Craneware PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
1%

Over the last year, the Cash & Cash Equivalents growth was -56%. The average annual Cash & Cash Equivalents growth rates for Craneware PLC have been -47% over the past three years , -6% over the past five years , and 1% over the past ten years .

Back to Top